BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30554453)

  • 1. Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.
    Wang K; Moon DH; Amdur RJ; Dagan R; Sheets NC; Shen CJ; Green R; Patel SN; Zanation AM; Thorp BD; Hackman TG; Weissler MC; Mendenhall WM; Chera BS
    Head Neck; 2019 May; 41(5):1213-1219. PubMed ID: 30554453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life.
    Wang K; Amdur RJ; Mendenhall WM; Green R; Aumer S; Hackman TG; Zanation AM; Zevallos JP; Patel SN; Weissler MC; Chera BS
    Oral Oncol; 2016 Jul; 58():21-6. PubMed ID: 27311398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
    Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
    Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of neck dissection on quality of life.
    Kuntz AL; Weymuller EA
    Laryngoscope; 1999 Aug; 109(8):1334-8. PubMed ID: 10443845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.
    Pearlstein KA; Wang K; Amdur RJ; Shen CJ; Dagan R; Weiss J; Grilley-Olson JE; Zanation A; Hackman TG; Thorp BD; Blumberg JM; Patel S; Sheets N; Weissler MC; Mendenhall WM; Chera BS
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):646-653. PubMed ID: 30395903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
    Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
    Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative brief electrical stimulation (BES) for prevention of shoulder dysfunction after oncologic neck dissection: study protocol for a randomized controlled trial.
    Barber B; McNeely M; Chan KM; Beaudry R; Olson J; Harris J; Seikaly H; O'Connell D
    Trials; 2015 May; 16():240. PubMed ID: 26021563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial.
    Wang K; Wong TZ; Amdur RJ; Mendenhall WM; Sheets NC; Green R; Thorp BD; Patel SN; Hackman TG; Zanation AM; Weissler MC; Chera BS
    Oral Oncol; 2018 Mar; 78():108-113. PubMed ID: 29496037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
    Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
    Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.
    Hegde JV; Shaverdian N; Daly ME; Felix C; Wong DL; Rosove MH; Garst JH; Wang PC; Veruttipong D; Rao S; Fragoso RC; Riess JW; Steinberg ML; Chen AM
    Cancer; 2018 Feb; 124(3):521-529. PubMed ID: 29044458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of neck and shoulder morbidity following neck dissection: The benefits of cervical plexus preservation.
    Garzaro M; Riva G; Raimondo L; Aghemo L; Giordano C; Pecorari G
    Ear Nose Throat J; 2015 Aug; 94(8):330-44. PubMed ID: 26322451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection.
    Schiefke F; Akdemir M; Weber A; Akdemir D; Singer S; Frerich B
    Head Neck; 2009 Apr; 31(4):503-12. PubMed ID: 19156833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture in shoulder pain and functional impairment after neck dissection: A prospective randomized pilot study.
    Deganello A; Battat N; Muratori E; Cristofaro G; Buongiorno A; Mannelli G; Picconi M; Giachetti R; Borsotti G; Gallo O
    Laryngoscope; 2016 Aug; 126(8):1790-5. PubMed ID: 27010596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
    Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
    Burgin SJM; Spector ME; Pearson AT; Bellile E; Vainshtein JM; Rosko A; Mclean SA; Bradford CR; Wolf GT; Prince ME; Worden FP; Eisbruch A; Chepeha DB
    Head Neck; 2021 May; 43(5):1621-1628. PubMed ID: 33580560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of 3 patient-reported outcome measures for the assessment of shoulder disability after neck dissection.
    Stuiver MM; ten Tusscher MR; van Opzeeland A; Brendeke W; Lindeboom R; Dijkstra PU; Aaronson NK
    Head Neck; 2016 Jan; 38(1):102-10. PubMed ID: 25224150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric Oxygen as Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx: A Phase 1 Dose-Escalation Study.
    Hartford AC; Davis TH; Buckey JC; Foote RL; Sinesi MS; Williams BB; Fariss AK; Schaner PE; Claus PL; Okuno SH; Hussey JR; Clarke RE
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):481-486. PubMed ID: 28126298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Multimodality Neck Treatment and Work and Leisure Impairment: A Disease-Specific Measure to Assess Both Impairment and Rehabilitation After Neck Dissection.
    Gallagher KK; Sacco AG; Lee JS; Taylor R; Chanowski EJ; Bradford CR; Prince ME; Moyer JS; Wolf GT; Worden FP; Eisbruch A; Chepeha DB
    JAMA Otolaryngol Head Neck Surg; 2015 Oct; 141(10):888-93. PubMed ID: 26426565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).
    Ringash J; Waldron JN; Siu LL; Martino R; Winquist E; Wright JR; Nabid A; Hay JH; Hammond A; Sultanem K; Hotte S; Leong C; El-Gayed AA; Naz F; Ramchandar K; Owen TE; Montenegro A; O'Sullivan B; Chen BE; Parulekar WR
    Eur J Cancer; 2017 Feb; 72():192-199. PubMed ID: 28040660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.